Ralaniten acetate
Names
[ CAS No. ]:
1637573-02-4
[ Name ]:
Ralaniten acetate
Biological Activity
[Description]:
A novel small-molecule inhibitor of androgen receptor (AR) N-terminal domain inhibitor for the treatment of advanced prostate cancer; AR NTD-targeting agents have the potential to overcome shortcomings of current hormonal therapies by inhibiting all forms of AR-mediated transcriptional activity, and as a result, may affect a broader AR population including mutational and splice variant ARs. Prostate Cancer Phase 2 Clinical
[References]
References 1. Antonarakis ES, et al. Oncologist. 2016 Dec;21(12):1427-1435. View Related Products by Target Estrogen Receptor/ERR Prostate Cancer
Chemical & Physical Properties
[ Molecular Formula ]:
C23H29ClO6
[ Molecular Weight ]:
436.929